Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Total Valuation
Elevance Health has a market cap or net worth of $84.93B. The enterprise value is $139.84B.
Market Cap$84.93B
Enterprise Value$139.84B
Share Statistics
Elevance Health has 225,934,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding225,934,600
Owned by Insiders0.14%
Owned by Institutions27.17%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 6.44%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.44%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.70M
Profits Per Employee57.30K
Employee Count104,200
Asset Turnover1.51
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 14.37. Elevance Health’s PEG ratio is -10.93.
PE Ratio14.37
PS Ratio0.00
PB Ratio3.39
Price to Fair Value2.08
Price to FCF16.99
Price to Operating Cash Flow14.66
PEG Ratio-10.93
Income Statement
In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 26.29.
Revenue176.81B
Gross Profit157.06B
Operating Income7.90B
Pretax Income7.90B
Net Income5.98B
EBITDA9.09B
Earnings Per Share (EPS)26.29
Cash Flow
In the last 12 months, operating cash flow was 4.85B and capital expenditures -1.17B, giving a free cash flow of 3.67B billion.
Operating Cash Flow4.85B
Free Cash Flow3.67B
Free Cash Flow per Share16.26
Dividends & Yields
Elevance Health pays an annual dividend of $1.71, resulting in a dividend yield of 1.82%
Dividend Per Share$1.71
Dividend Yield1.82%
Payout Ratio38.95%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change-28.55%
50-Day Moving Average401.07
200-Day Moving Average418.90
Relative Strength Index (RSI)41.88
Average Volume (3m)1.76M
Important Dates
Elevance Health upcoming earnings date is Jul 16, 2025, TBA Not Confirmed.
Last Earnings DateApr 22, 2025
Next Earnings DateJul 16, 2025
Ex-Dividend DateJun 10, 2025
Financial Position
Elevance Health as a current ratio of 2.01, with Debt / Equity ratio of 66.42%
Current Ratio2.01
Quick Ratio2.01
Debt to Market Cap0.36
Net Debt to EBITDA2.52
Interest Coverage Ratio6.67
Taxes
In the past 12 months, Elevance Health has paid 1.93B in taxes.
Income Tax1.93B
Effective Tax Rate0.24
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 11.98, with an EV/FCF ratio of 23.91.
EV to Sales0.62
EV to EBITDA11.98
EV to Free Cash Flow23.91
EV to Operating Cash Flow18.74
Balance Sheet
Elevance Health has $7.50B in cash and marketable securities with $30.00B in debt, giving a net cash position of $22.50B billion.
Cash & Marketable Securities$7.50B
Total Debt$30.00B
Net Cash$22.50B
Net Cash Per Share$99.60
Tangible Book Value Per Share$4.53
Margins
Gross margin is 25.51%, with operating margin of 4.47%, and net profit margin of 3.38%.
Gross Margin25.51%
Operating Margin4.47%
Pretax Margin4.47%
Net Profit Margin3.38%
EBITDA Margin5.14%
EBIT Margin5.14%
Analyst Forecast
The average price target for Elevance Health is $498.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$498.00
Price Target Upside32.48% Upside
Analyst ConsensusStrong Buy
Analyst Count16
Revenue Growth Forecast6.63%
EPS Growth Forecast-3.26%